57664-419 : Asa 356.4 mg / Caffeine 30 mg / Dihydrocodeine Bitartrate 16 mg Oral Capsule


NDC57664-419
Labeler: Caraco Pharmaceutical Laboratories, Ltd
Product Type: Human Prescription Drug
Drug Name:  Aspirin, Caffeine, and Dihydrocodeine Bitartrate
Dosage Form: Oral Capsule
Application #: NDA011483
Rev. Date: 
CSA Schedule: CIII (US) [1]


[1] Schedule III / IIIN Controlled Substance: Has a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. (i.e. Products containing not more than 90 milligrams of Codeine per dosage unit [such as Tylenol with Codeine], other narcotics such as Buprenorphine (Suboxone), and Schedule IIIN non-narcotics such as Didrex, Ketamine, Phendimetrazine, and Anabolic Steroids). More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: CP;419
Shapes:  Capsule
Colors:  Blue / Gray
Size (mm): 19
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 57664-419-88: 100 CAPSULE IN 1 BOTTLE (57664‑419‑88)

Active Ingredients:

  • Aspirin
  • Caffeine
  • Dihydrocodeine Bitartrate

Dosage Strength:

  • 356.4 mg
  • 30 mg
  • 16 mg

Inactive Ingredients:

  • Alginic Acid
  • Cellulose, Microcrystalline
  • D&c Red No. 28
  • Fd&c Blue No. 1
  • Gelatin
  • Ferrosoferric Oxide
  • Stearic Acid
  • Titanium Dioxide

Pharmaceutical Classes:

  • Cyclooxygenase Inhibitors [MoA]
  • Decreased Prostaglandin Production [PE]
  • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • Decreased Platelet Aggregation [PE]
  • Central Nervous System Stimulant [EPC]
  • Methylxanthine [EPC]
  • Xanthines [CS]
  • Central Nervous System Stimulation [PE]
  • Full Opioid Agonists [MoA]
  • Opioid Agonist [EPC]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 57664-419 QR Code

< Prev: 57664-399Next: 57664-421 >

Related Discussions:

Aspirin ASA Caffeine Salicylamide tablets
I am looking for tablets. The powder taste terrible!!! ## Have you tried asking your local pharmacy about other alternat... 1 reply
orphenadrine aspirin caffeine
WHERE CAN I GET THIS DRUG NOW MY DRUGSTORE HERE IN TOWN SAYS ITS UNAVAILABLE PLEASE LET ME KNOW WHERE I CAN GET IT I HAV... 1 reply
Fiorinal (aspirin, butalbital, caffeine)
Information on uses, side effects, dosing, mechanism of action and other pharmacology. ## I am looking for information o... 3 replies
Butalbital 50 + Aspirin 325 + Caffeine 40
My boyfriend is a Vietnam Vet and he has a rod in his leg and suffers from migraines all the time sometimes 3 days strai... 2 replies
replacement for butalbital aspirin caffeine 50/325/50?
Is there a replacement for butalbital/aspirin/caffeine out there 50/325/50? It was the combo of the drug that worked for... 5 replies
Dihydrocodeine pain reliever
## What are the available milligrams of dihydrocodeine? ## They come in 30mg, 60mg and 120mg. I don't know if they g... 6 replies
Dihydrocodeine 30 mg
I get dfs as part of treatment for internal problems, (i.e. cd, I get prescribed 30mg white, some tablets have C D H and... 1 reply
Dihydrocodeine 55 mg pill show picture
Blue round pill with 55 on one side and crescent moon on other ## I had a whole post typed up, then I finally remembered... 1 reply
Can't get Dihydrocodeine in the UK
My Boots pharmacy can no longer get Dihydrocodeine fast and slow acting. Is it available at other pharmacies in Nottingh...
Bristol Laboratory Dihydrocodeine
I work away from home and find making an appt. with my GP hard. So my sciatica flared up and I filled my dihydrocodeine ... 4 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.